Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Genetics of Prostate Cancer (PDQ®): Health Professional Version.

PDQ Cancer Genetics Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2019 Oct 4.

2.

Association of statin use with risk of Gleason score-specific prostate cancer: A hospital-based cohort study.

Wang K, Gerke TA, Chen X, Prosperi M.

Cancer Med. 2019 Oct 8. doi: 10.1002/cam4.2500. [Epub ahead of print]

3.
4.

SATB2 Protein Expression by Immunohistochemistry is a Sensitive and Specific Marker of Appendiceal and Rectosigmoid Well Differentiated Neuroendocrine Tumors.

Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky J, Shi CC, Giannico GA.

Histopathology. 2019 Oct 9. doi: 10.1111/his.14012. [Epub ahead of print]

PMID:
31595536
5.

Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies.

Iravani A, Violet J, Azad A, Hofman MS.

Prostate Cancer Prostatic Dis. 2019 Oct 8. doi: 10.1038/s41391-019-0174-x. [Epub ahead of print] Review.

PMID:
31595044
6.

Translation and cultural adaptation of the web and printed versions of a decision aid to support men's prostate cancer screening choice: a protocol.

Baptista S, Heleno B, Pinto M, Teixeira A, Taylor KL, Martins C.

BMJ Open. 2019 Oct 7;9(10):e028938. doi: 10.1136/bmjopen-2019-028938.

7.

PGC1α suppresses prostate cancer cell invasion through ERRα transcriptional control.

Valcarcel-Jimenez L, Macchia A, Crosas-Molist E, Schaub-Clerigué A, Camacho L, Martín-Martín N, Cicogna P, Viera-Bardón C, Fernández-Ruiz S, Rodriguez-Hernandez I, Hermanova I, Astobiza I, Cortazar AR, Corres-Mendizabal J, Gomez-Muñoz A, Sanz-Moreno V, Torrano V, Carracedo A.

Cancer Res. 2019 Oct 8. pii: canres.1231.2019. doi: 10.1158/0008-5472.CAN-19-1231. [Epub ahead of print]

PMID:
31594836
8.

New Protocol of Intermittent Androgen Deprivation Therapy for Patients With Metastatic Prostate Cancer: A Retrospective Study.

Cai J, Feng G, Yan Y, Liu Z, Jing S.

Clin Genitourin Cancer. 2019 Aug 5. pii: S1558-7673(19)30243-5. doi: 10.1016/j.clgc.2019.07.015. [Epub ahead of print]

PMID:
31594735
9.

Focal Laser Ablation Versus Radical Prostatectomy for Localized Prostate Cancer: Survival Outcomes From a Matched Cohort.

Zheng X, Jin K, Qiu S, Han X, Liao X, Yang L, Wei Q.

Clin Genitourin Cancer. 2019 Aug 21. pii: S1558-7673(19)30257-5. doi: 10.1016/j.clgc.2019.08.008. [Epub ahead of print]

PMID:
31594734
10.

Re: Manfred Wirth, Nicola Fossati, Peter Albers, et al. The European Prostate Cancer Centres of Excellence: A Novel Proposal from the European Association of Urology Prostate Cancer Centre Consensus Meeting. Eur Urol 2019;76:179-86.

Wei Y, Zhang R, Ye L.

Eur Urol. 2019 Oct 5. pii: S0302-2838(19)30754-7. doi: 10.1016/j.eururo.2019.09.026. [Epub ahead of print] No abstract available.

PMID:
31594706
11.

Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study.

Thiery-Vuillemin A, Hvid Poulsen M, Lagneau E, Ploussard G, Birtle A, Dourthe LM, Beal-Ardisson D, Pintus E, Trepiakas R, Lefresne F, Lukac M, Van Sanden S, Pissart G, Reid A; AQUARiUS Investigators.

Eur Urol. 2019 Oct 5. pii: S0302-2838(19)30739-0. doi: 10.1016/j.eururo.2019.09.019. [Epub ahead of print]

PMID:
31594705
12.

A sensitive thrombin-linked sandwich immunoassay for protein targets using high affinity phosphorodithioate modified aptamer for thrombin labeling.

Wang C, Sun Y, Zhao Q.

Talanta. 2020 Jan 15;207:120280. doi: 10.1016/j.talanta.2019.120280. Epub 2019 Aug 19.

PMID:
31594565
13.

Quality of life and functional outcomes after surgery for spinal metastases: Results of a cohort study.

Westermann L, Eysel P, Luge H, Olivier A, Oikonomidis S, Baschera D, Zarghooni K.

Technol Health Care. 2019 Sep 20. doi: 10.3233/THC-191727. [Epub ahead of print]

PMID:
31594268
14.

Association between tumor necrosis factor-alpha gene rs1800629 (-308G/A) and rs361525 (-238G > A) polymorphisms and prostate cancer risk in an Iranian cohort.

Alidoost S, Habibi M, Noormohammadi Z, Hosseini J, Azargashb E, Pouresmaeili F.

Hum Antibodies. 2019 Sep 27. doi: 10.3233/HAB-190397. [Epub ahead of print]

PMID:
31594215
15.

[What causes prostate cancer: patient-perceived causes].

Goethe VE, Dinkel A, Schulwitz H, Nöhreiter A, Gschwend JE, Herkommer K.

Aktuelle Urol. 2019 Oct 8. doi: 10.1055/a-1005-6273. [Epub ahead of print] German.

PMID:
31594005
16.

Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.

Shen Z, Zhou L, Zhang C, Xu J.

Cancer Lett. 2019 Oct 5. pii: S0304-3835(19)30497-5. doi: 10.1016/j.canlet.2019.10.006. [Epub ahead of print]

PMID:
31593800
17.

Hyprofractionated versus conventionally fractionated radiotherapy for patients with intermediate- or high-risk, localized, prostate cancer: 7-year outcomes from the randomized, multi-centre, open-label, phase 3 HYPRO trial.

de Vries KC, Wortel RC, Hoop EO, Heemsbergen WD, Pos FJ, Incrocci PL.

Int J Radiat Oncol Biol Phys. 2019 Oct 5. pii: S0360-3016(19)33827-1. doi: 10.1016/j.ijrobp.2019.09.007. [Epub ahead of print]

PMID:
31593756
18.

Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment.

Schelb P, Kohl S, Radtke JP, Wiesenfarth M, Kickingereder P, Bickelhaupt S, Kuder TA, Stenzinger A, Hohenfellner M, Schlemmer HP, Maier-Hein KH, Bonekamp D.

Radiology. 2019 Oct 8:190938. doi: 10.1148/radiol.2019190938. [Epub ahead of print]

PMID:
31592731
19.

An Examination of John Henryism, Trust, and Medication Adherence Among African Americans With Hypertension.

Cuffee YL, Hargraves L, Rosal M, Briesacher BA, Allison JJ, Hullett S.

Health Educ Behav. 2019 Oct 8:1090198119878778. doi: 10.1177/1090198119878778. [Epub ahead of print]

PMID:
31592686
20.

Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.

Sailer V, Eng KW, Zhang T, Bareja R, Pisapia DJ, Sigaras A, Bhinder B, Romanel A, Wilkes D, Sticca E, Cyrta J, Rao R, Sahota S, Pauli C, Beg S, Motanagh S, Kossai M, Fontunge J, Puca L, Rennert H, Zhaoying Xiang J, Greco N, Kim R, MacDonald TY, McNary T, Blattner-Johnson M, Schiffman MH, Faltas BM, Greenfield JP, Rickman D, Andreopoulou E, Holcomb K, Vahdat LT, Scherr DS, van Besien K, Barbieri CE, Robinson BD, Fine HA, Ocean AJ, Molina A, Shah MA, Nanus DM, Pan Q, Demichelis F, Tagawa ST, Song W, Mosquera JM, Sboner A, Rubin MA, Elemento O, Beltran H.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.19.00047. Epub 2019 Sep 20.

PMID:
31592503

Supplemental Content

Loading ...
Support Center